HbA1c and Coronary Heart Disease Risk among Diabetic Patients HbA1c and CHD risk in diabetic patients

Diabetes Care October 15, 2013

Objective Clinical trials to date have not provided definitive evidence regarding the effects of glucose lowering with coronary heart disease (CHD) risk among diabetic patients.

Research Design and Methods We prospectively investigated the association of HbA1c at baseline and during follow-up with CHD risk among 17,510 African American and 12,592 White patients with type 2 diabetes.Read More